COLUMBUS, Ohio – June 1, 2021 – Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced today that its CEO, President and Co-Founder Timothy J. Miller, Ph.D., will present at the Jefferies Virtual Healthcare Conference being held June 1-4, 2021. Dr. Miller will provide a company overview, detailing the company’s growth from its launch in July 2020 with $40 million in Series A financing, to an additional $120 million Series B round in less than a year.
Jefferies Virtual Healthcare Conference – June 1-4, 2021
Date: Friday, June 4, 2021
Time: 11:30-11:55am EST
Webcast: virtual webinar link here or https://wsw.com/webcast/jeff174/forge/1996245
Webcast replay link: A replay will be accessible on the Insights page of the company website at https://insights.forgebiologics.com
About Forge Biologics
Forge Biologics is a hybrid gene therapy contract manufacturing and therapeutics development company. Forge’s mission is to enable access to life changing gene therapies and help bring them from idea into reality. Forge has a 175,000 ft2 facility in Columbus, Ohio, “The Hearth,” to serve as its headquarters. The Hearth is the home of a custom-designed cGMP facility dedicated to AAV viral vector manufacturing and will host end-to-end manufacturing services to accelerate gene therapy programs from preclinical through clinical and commercial stage manufacturing. By taking a patients-first approach, Forge aims to accelerate the timelines of these transformative medicines for those who need them the most. For more information, please visit www.forgebiologics.com.
Magdalena Tyrpien – Forge Biologics
Vice President and Head of Business Development
Christina Perry – Forge Biologics
Vice President, Finance and Operations
Patient, Pediatrician, Genetic Counselors & Family Inquiries
Dr. Maria Escolar – Forge Biologics
Chief Medical Officer